1. Home
  2. PXLW vs ATOS Comparison

PXLW vs ATOS Comparison

Compare PXLW & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$6.06

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$5.00

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
ATOS
Founded
1997
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
36.2M
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
PXLW
ATOS
Price
$6.06
$5.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.33
$31.67
AVG Volume (30 Days)
25.7K
82.0K
Earning Date
06-11-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
$693,000.00
$1,758.00
Revenue This Year
$5,066.23
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.53
52 Week High
$15.42
$7.56

Technical Indicators

Market Signals
Indicator
PXLW
ATOS
Relative Strength Index (RSI) 47.96 66.06
Support Level $5.67 $0.68
Resistance Level $6.77 $5.12
Average True Range (ATR) 0.29 0.35
MACD -0.01 -0.06
Stochastic Oscillator 39.13 68.29

Price Performance

Historical Comparison
PXLW
ATOS

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: